Inhaled Mometasone to Promote Reduction in Vasoocclusive Events
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Mometasone (Primary)
- Indications Respiration disorders; Sickle cell anaemia
- Focus Therapeutic Use
- Acronyms IMPROVE
- 05 Apr 2017 Planned End Date changed from 1 Feb 2017 to 1 Nov 2017.
- 05 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Nov 2017.
- 17 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.